#269 - Good vs. bad science: how to read and understand scientific studies

#269 - Good vs. bad science: how to read and understand scientific studies

View the Show Notes Page for This Episode

Become a Member to Receive Exclusive Content

Sign Up to Receive Peter's Weekly Newsletter

This special episode is a rebroadcast of AMA #30, now made available to everyone, in which Peter and Bob Kaplan dive deep into all things related to studying studies to help one sift through the noise to find the signal. They define various types of studies, how a study progresses from idea to execution, and how to identify study strengths and limitations. They explain how clinical trials work, as well as biases and common pitfalls to watch out for. They dig into key factors that contribute to the rigor (or lack thereof) of an experiment, and they discuss how to measure effect size, differentiate relative risk from absolute risk, and what it really means when a study is statistically significant. Finally, Peter lays out his personal process when reading through scientific papers.

We discuss:

  • The ever-changing landscape of scientific literature [2:30];
  • The process for a study to progress from idea to design to execution [5:00];
  • Various types of studies and how they differ [8:00];
  • The different phases of clinical trials [19:45];
  • Observational studies and the potential for bias [27:00];
  • Experimental studies: randomization, blinding, and other factors that make or break a study [44:30];
  • Power, p-values, and statistical significance [56:45];
  • Measuring effect size: relative risk vs. absolute risk, hazard ratios, and "number needed to treat" [1:08:15];
  • How to interpret confidence intervals [1:18:00];
  • Why a study might be stopped before its completion [1:24:00];
  • Why only a fraction of studies are ever published and how to combat publication bias [1:32:00];
  • Frequency of training for Olympic weightlifting [1:22:15];
  • How post-activation potentiation (and the opposite) can improve power training and speed training [1:24:30];
  • The Strongman competition: more breadth of movement, strength, and stamina [1:32:00];
  • Why certain journals are more respected than others [1:41:00];
  • Peter's process when reading a scientific paper [1:44:15]; and
  • More.

Connect With Peter on Twitter, Instagram, Facebook and YouTube

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(454)

#406 ‒ Migraine, cluster headache, and tension headache: symptoms, causes, prevention, and treatment | Brian Grosberg, M.D.

#406 ‒ Migraine, cluster headache, and tension headache: symptoms, causes, prevention, and treatment | Brian Grosberg, M.D.

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter Brian Grosberg is a world-renowned headache specialist who joins P...

31 Aug 1h 55min

#405 ‒ AMA #88: Metabolic liver health: how to assess risk, catch dysfunction early, and prevent or reverse liver disease

#405 ‒ AMA #88: Metabolic liver health: how to assess risk, catch dysfunction early, and prevent or reverse liver disease

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this "Ask Me Anything" (AMA) episode, Peter takes a deep dive i...

24 Aug 39min

#404 ‒ Mental health beyond neurotransmitters: the role of hormones in psychiatry, why symptom reduction isn't enough, and the future of psychedelic therapies | Linus Abrams, M.D.

#404 ‒ Mental health beyond neurotransmitters: the role of hormones in psychiatry, why symptom reduction isn't enough, and the future of psychedelic therapies | Linus Abrams, M.D.

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this episode, Peter sits down with Dr. Linus Abrams, a psychiat...

17 Aug 2h 17min

#403 ‒ Peptides: separating scientific promise from marketing hype

#403 ‒ Peptides: separating scientific promise from marketing hype

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this episode, Peter returns to the topic of peptides, offering ...

10 Aug 53min

#402 ‒ NMR blood analysis: how heart disease risk, insulin resistance, inflammation, and mortality risk can be assessed from a single blood sample | Jim Otvos, Ph.D.

#402 ‒ NMR blood analysis: how heart disease risk, insulin resistance, inflammation, and mortality risk can be assessed from a single blood sample | Jim Otvos, Ph.D.

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter Jim Otvos is a biophysical chemist who pioneered the use of nuclea...

3 Aug 2h 25min

#401 ‒ How curiosity transforms medicine: extraordinary discoveries that changed modern healthcare

#401 ‒ How curiosity transforms medicine: extraordinary discoveries that changed modern healthcare

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this episode of The Drive, Peter explores how seemingly obscure...

27 Juli 1h 4min

#400 ‒ AMA #87: Environmental pollution and longevity: air pollution, noise, light, EMFs, and practical strategies to mitigate health risks

#400 ‒ AMA #87: Environmental pollution and longevity: air pollution, noise, light, EMFs, and practical strategies to mitigate health risks

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this "Ask Me Anything" (AMA) episode, Peter explores the eviden...

20 Juli 19min

#399 ‒ The evolution of Alzheimer's disease and dementia care: how early detection, personalized treatment, new therapies, and a multimodal approach are changing the landscape | Gayatri Devi, M.D.

#399 ‒ The evolution of Alzheimer's disease and dementia care: how early detection, personalized treatment, new therapies, and a multimodal approach are changing the landscape | Gayatri Devi, M.D.

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter Gayatri Devi is a nationally recognized neurologist specializing i...

13 Juli 1h 56min

Populärt inom Hälsa

somna-med-henrik
rss-jossan-nina
bullfika
inga-beiga-morsor
rss-bara-en-till-om-beroende-medberoende
rss-vuxna-pa-latsas
not-fanny-anymore
rss-viktmedicinpodden
sexnoveller-deluxe
angestpodden
johannes-hansen-podcast
sa-in-i-sjalen
rss-hos-psykologen
rss-basta-livet
tyngre-traningssnack
sova-med-dan-horning
rss-traningsklubben
medicinvetarna
halsorevolutionen
rss-angra-inget-3